Physician profile
Travis Baird
NPI 1235548314
$11,488.34
in general payments reported to CMS, 2019-2025
44 companies · $4,786 in 2025
The $4,786 reported for 2025 was more than what 98% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,763 · 2022: $1,878 · 2023: $1,047 · 2024: $2,015 · 2025: $4,786.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,215 · Travel and Lodging: $624 · Education: $8.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,215.41 |
| Travel and Lodging | $623.84 |
| Education | $8.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $1,388.69 | 2023-2025 | Spravato, Invega Sustenna, Invega Trinza |
| Abbvie INC. | $1,125.36 | 2021-2025 | |
| Neuronetics, INC. | $1,021.98 | 2022-2025 | Neurostar Tms Therapy System |
| Collegium Pharmaceutical, INC. | $633.36 | 2021-2025 | Jornay Pm |
| Otsuka America Pharmaceutical, INC. | $553.02 | 2021-2025 | Rexulti, Abilify Asimtufii, Abilify Maintena |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $544.56 | 2021-2023 | Relistor |
| E.R. Squibb & Sons, L.L.C. | $541.21 | 2024-2025 | Cobenfy |
| Gilead Sciences, INC. | $513.51 | 2023-2025 | Epclusa |
| Supernus Pharmaceuticals, INC. | $450.74 | 2024-2025 | Qelbree |
| Alkermes, INC. | $437.44 | 2024-2025 | Aristada, Lybalvi, Vivitrol |
| Neurocrine Biosciences, INC. | $426.00 | 2024-2025 | Ingrezza |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $404.56 | 2024-2025 | Caplyta |
| Lundbeck LLC | $317.16 | 2023-2025 | Rexulti, Abilify Asimtufii, Abilify Maintena |
| Vanda Pharmaceuticals INC. | $295.90 | 2022-2025 | Fanapt, Hetlioz |
| Almatica Pharma LLC | $291.24 | 2021-2025 | Loreev Xr |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Travis Baird listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.